Kohl’s Poison Pill Won’t Kill Potential Sale

Kohl’s has hired Goldman Sachs and PJT Partners to field interest from potential buyers.



Photo:

Justin Sullivan/Getty Images

A poison pill is clearly a tough one for

Kohl’s


KSS -2.00%

activist investor Macellum to swallow.

Macellum on Thursday nominated a slate of 10 directors to Kohl’s board, which currently seats 14 members, including two that Macellum plus a group of investors had picked as part…

Read more…

spot_imgspot_img

Latest news

Related news

LEAVE A REPLY

Please enter your comment!
Please enter your name here